EUVIMEDEUVIMED entdecken
Crossref

T790M mutation upconversion fluorescence biosensor via mild ATRP strategy and site-specific DNA cleavage of restriction endonuclease

Yanju Liu, Liang Guo, Mengyuan Hou, Haiyang Gao, Yuanmeng Ke, Huaixia Yang, Fuchun Si

Microchimica Acta · 2024

DOI: 10.1007/s00604-024-06229-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2024. Verfasst von Yanju Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, People's Republic of China. Hauptthemen laut MEDLINE: Lung Neoplasms, Biosensing Techniques. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: the project of tackling of key scientific and technical problems in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A unique combination of a specific nucleic acid restriction endonuclease (REase) and atom transfer radical polymerization (ATRP) signal amplification strategy was employed for the detection of T790M mutations prevalent in the adjuvant diagnosis of lung cancer. REase selectively recognizes and cleaves T790M mutation sites on double-stranded DNA formed by hybridization of a capture sequence and a target sequence. At the same time, the ATRP strategy resulted in the massive aggregation of upconverted nanoparticles (UCNPs), which significantly improved the sensitivity of the biosensor. In addition, the UCNPs have excellent optical properties and can eliminate the interference of autofluorescence in the samples, thus further improving the detection sensitivity. The proposed upconversion fluorescent biosensor is characterized by high specificity, high sensitivity, mild reaction conditions, fast response time, and a detection limit as low as 0.14 fM. The performance of the proposed biosensor is comparable to that of clinical PCR methods when applied to clinical samples. This work presents a new perspective for assisted diagnosis in the pre-intervention stage of tumor diagnostics in the early stage of precision oncology treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsBiosensing TechniquesHumansDNA Restriction EnzymesErbB ReceptorsPolymerizationDNA CleavageLimit of DetectionMutationPrecision MedicineProtein Kinase Inhibitors

Stichwörter der Autor:innen

Atom transfer radical polymerizationFluorescence biosensorRestriction endonucleaseT790MUpconversion nanoparticles

Substanzen

DNA Restriction EnzymesErbB ReceptorsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, People's Republic of China.
  • Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, People's Republic of China. yanghuaixia886@163.com.
  • Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, People's Republic of China. sifc2000@hotmail.com.

Förderung

  • the project of tackling of key scientific and technical problems in Henan Province

Zitieren

APA

Liu, Y., Guo, L., Hou, M., Gao, H., Ke, Y., Yang, H., & Si, F. (2024). T790M mutation upconversion fluorescence biosensor via mild ATRP strategy and site-specific DNA cleavage of restriction endonuclease. Microchimica Acta. https://doi.org/10.1007/s00604-024-06229-z

Vancouver

Liu Y, Guo L, Hou M, Gao H, Ke Y, Yang H, et al. T790M mutation upconversion fluorescence biosensor via mild ATRP strategy and site-specific DNA cleavage of restriction endonuclease. Microchimica Acta. 2024. doi:10.1007/s00604-024-06229-z

BibTeX
@article{Liu2024,
  author = {Liu, Yanju and Guo, Liang and Hou, Mengyuan and Gao, Haiyang and Ke, Yuanmeng and Yang, Huaixia and Si, Fuchun},
  title = {T790M mutation upconversion fluorescence biosensor via mild ATRP strategy and site-specific DNA cleavage of restriction endonuclease},
  journal = {Microchimica Acta},
  year = {2024},
  doi = {10.1007/s00604-024-06229-z}
}
Kostenlos starten →